Vitamin D Treatment in Hemodialysis patients

Phase 2

• Conditions: Anemia in patients with End Stage Kidney Disease (ESRD).; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20190107042264N4
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients Undergoing Hemodialysis at least once weekly due to ESRD
Treatment with erythropoietin
Serum 25-hydroxy vitamin D content less than 30 nanograms/milliliter

Exclusion Criteria

Serum 25-hydroxy vitamin D content more than 30 nanograms/milliliter

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Hemoglobin level. Timepoint: before intervention, 3 months after intervention. Method of measurement: Complete Blood Count.